Benzinga | Nov 10, 2021 05:41PM EST

Spero Therapeutics Q3 EPS $(0.70) Misses $(0.66) Estimate, Sales $3.06M Miss $4.47M Estimate

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.66) by 6.06 percent. This is a 18.6 percent increase over losses of $(0.86) per share from the same period last year. The company reported quarterly sales of $3.06 million which missed the analyst consensus estimate of $4.47 million by 31.45 percent. This is a 23.30 percent decrease over sales of $4.00 million the same period last year.